Infinair LD 2.5 mg/4 mg Tablet DT may cause excessive drowsiness and calmness with alcohol.

Infinair LD 2.5 mg/4 mg Tablet DT is probably safe to use during pregnancy.Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.

Infinair LD 2.5 mg/4 mg Tablet DT is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.

Infinair LD 2.5 mg/4 mg Tablet DT may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

Infinair LD 2.5 mg/4 mg Tablet DT should be used with caution in patients with kidney disease. Dose adjustment of Infinair LD 2.5 mg/4 mg Tablet DT may be needed. Please consult your doctor.Use of Infinair LD 2.5 mg/4 mg Tablet DT is not recommended in patients with severe kidney disease.

Infinair LD 2.5 mg/4 mg Tablet DT should be used with caution in patients with severe liver disease. Dose adjustment of Infinair LD 2.5 mg/4 mg Tablet DT may be needed. Please consult your doctor.Limited information is available on the use of Infinair LD 2.5 mg/4 mg Tablet DT in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.